Default company panoramic image
Logo

BioHealthonomics

Patent pending, industry unique approach for the treatment and prevention of migraine headaches with an estimated 16X ROI.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Santa Monica, CA, USA
  • Currency USD
  • Founded July 2011
  • Employees 3
  • Incorporation Type C-corp
  • Website biohealthonomics.com

Company Summary

BioHealthonomics is a research and development biotechnology & healthcare company dedicated to developing and commercializing high-impact, effective and side effect free therapeutics that address critical unmet needs in the treatment of migraines, Parkinson's disease, AD and ALS. The company will develop both a product (histamine dihydrochloride) and a proprietary protocol for conditions' treatment and prevention. Projected ROI multiples: 16X

Team

  • Mr. Arnou is the BioHealthonomics Inc. Founder and CEO. As a migraine sufferer for more than 35 years he is determined and committed to implementing the migraine cure throughout the U.S. via existing medical offices. For the past 4 years, Mr. Arnou has worked for two start-up companies, Fisker Automotive and Coda Automotive, and knows what it takes to build a successful, prosperous business.

  • Default avatar
    Dr. James Sherry, MD, PhD
    Consultant (xFDA.com)
    Unconfirmed

    James H Sherry, MD, PhD is a former Medical Officer in the Division of Neuropharmacologic Drug Products (DNDP) at the Food and Drug Administration (FDA). He is a Diplomat of the American Board of Psychiatry and Neurology. He graduated from West Virginia University, School of Medicine. He received his M.D. degree in 1987 and his Ph.D. degree in 1988. Dr. Sherry has over 20 years of clinical and regulatory experience.

Advisors

  • Default avatar
    Dr. Max Talbott
    Advisory Board Member
    Unconfirmed

Previous Investors